Abbott India Limited (BOM:500488)
India · Delayed Price · Currency is INR 26,936
+24 (0.09%)
At close: Sep 25, 2026
Abbott India Market Cap
Abbott India has a market cap or net worth of 572.37 billion as of September 25, 2026. Its market cap has decreased by -10.67% in one year.
Market Cap
572.37B
Enterprise Value
551.76B
Revenue
70.04B
Ranking
n/a
PE Ratio
35.45
Stock Price
26,935.80
ChartMarket Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 572.37B, an increase of 11,901.12%. That is a compound annual growth rate of 21.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 572.37B | -7.34% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.88T |
| Dr. Reddy's Laboratories | 999.91B |
| Lupin | 959.28B |
| GlaxoSmithKline Pharmaceuticals | 487.30B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Caplin Point Laboratories | 217.83B |
| Granules India | 213.11B |
| AstraZeneca Pharma India | 167.73B |